We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Fatal Reaction Following the Ingestion of Meprobamate

E. Victor Adlin; Paul B. Sher; Nathaniel G. Berk
AMA Arch Intern Med. 1958;102(3):484-489. doi:10.1001/archinte.1958.00030010484022.
Text Size: A A A
Published online


Meprobamate (2-methyl-2-n-propyl-1,3-propanediol dicarbamate [Miltown, Equanil]) has become widely used as an ataractic or tranquilizing drug since its clinical introduction in 1955. The rarity and mildness of its side-effects, as described in early reports of clinical trials,1,2 encouraged its liberal use in many conditions characterized by anxiety and tension. In recent months, however, numerous reports of untoward reactions to this drug have appeared in the literature. We wish to present a case which we strongly suspect of representing a fatal reaction to meprobamate.

Report of Case  A 50-year-old white housewife entered the Albert Einstein Medical Center, Northern Division, on Aug. 14, 1957, at 11:30 p. m., complaining of fever, nausea and vomiting, and a widespread erythematous rash.Fourteen days before admission the patient had taken for the first time 2 or 3 tablets of Meprolone-2 (2 mg. of prednisolone, 200 mg. of meprobamate, and 200 mg. of dried aluminum hydroxide gel), which had been


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

7 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.